Boston Scientific COMET Wire Validation Study (COMET)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02578381 |
|
Recruitment Status :
Completed
First Posted : October 19, 2015
Last Update Posted : May 17, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Summary of Study Aims
To assess, in a randomised fashion:
- performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire
- performance of Boston Scientific Pressure Wire versus Boston Scientific Pressure Wire
- performance of St Jude Pressure Wire versus St Jude Pressure Wire
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Stable Angina | Device: Boston Scientific Pressure Wire Device: Validation of Boston Scientific pressure wire | Not Applicable |
Given the following key points of evidence, the optimal management of chest pain patients who come to diagnostic coronary angiography would more often be achieved if there was concomitant data with regard to the presence of patient-specific and lesion-specific ischaemia:
- that it is the presence and extent of reversible myocardial ischaemia (RMI) that dominates over coronary anatomy as a predictor of near term cardiovascular events, as well as symptom relief
- that prognostic benefit after revascularisation is greatest in patients with the largest pre-procedure ischaemic burden
- that intra-coronary pressure wire (PW) data are strongly correlated with subsequent cardiac events despite the binary nature of the test
- that stenting of coronary lesions that are PW negative has a worse outcome than optimal medical therapy (OMT)
- that PW-directed percutaneous coronary intervention (PCI) in multivessel disease is associated with a better clinical outcome than angiogram-directed PCI despite fewer treated lesions and less stents
- that PW-directed PCI improves prognosis compared to OMT
- that mismatch exists in up to 30-40% of lesions encountered at angiography between the visual appearance of the severity of the lesion and whether the lesion is "ischaemic" (and therefore a target for revascularisation) according to PW.
The availability of PW has been shown to have had a substantial effect on overall management of patients undergoing diagnostic coronary angiography (ie when options are still OMT/PCI and coronary artery bypass grafting (CABG) in several observation studies including RIPCORD and the French Registry.
Yet, despite the seemingly persuasive data summarised here, the uptake of PW at the diagnostic stage of the patient pathway is still low. There are, as yet, no suitably powered randomised trials using the PW systematically at the stage of diagnostic angiography and comparing outcome with management based upon angiography alone. This is the gap that will be filled by RIPCORD2.
RIPCORD2 will use the new Boston Scientific Pressure Wire (BSPW), which is currently undergoing first-in-man testing in Chile. The device has, of course, already been internally validated by Boston Scientific engineers and scientists, but the purpose of the COMET study is to provide independent and objective validation of the performance of BSPW using the performance of the St Jude Medical pressure wire (SJPW) as the reference, both using inter-wire and intra-wire measurements. Thus, not only will we assess the reproducibility of the measurements between the 2 wires, but the investigators will also compare reproducibility of measurements from 2 wires of the same manufacturer.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 106 participants |
| Allocation: | Randomized |
| Intervention Model: | Factorial Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Boston Scientific COMET Wire Validation Study |
| Actual Study Start Date : | March 16, 2016 |
| Actual Primary Completion Date : | November 14, 2016 |
| Actual Study Completion Date : | November 14, 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Boston Scientific PW versus St Jude PW
Performance of Boston Scientific PW vs St Jude PW
|
Device: Boston Scientific Pressure Wire
St Jude Medical Pressure Wire Device: Validation of Boston Scientific pressure wire |
|
Experimental: Boston Sci PW vs Boston Sci PW
Boston Sci PW vs Boston Sci PW
|
Device: Boston Scientific Pressure Wire
St Jude Medical Pressure Wire Device: Validation of Boston Scientific pressure wire |
|
Active Comparator: St Jude PW versus St Jude PW
Performance of St Jude PW vs St Jude PW
|
Device: Validation of Boston Scientific pressure wire |
- Coronary artery pressure as measured by Boston Scientific Pressure Wire (BSPW) [ Time Frame: Day one ]
The study will involve the use of two pressure wires simultaneously in a coronary artery.
The three randomisation groups will allow the comparison of pressure measurements between two different wires (BSPW vs SJPW) and will document consistency of readings within the same wire (BSPW vs BSPW or SJPW vs SJPW). Measurements will be undertaken using standard drug protocols. No additional drugs will be necessary for study purposes.
- The first wire allocated at randomisation will be passed to the target measurement position in the artery
- The second wire allocated at randomisation will be passed to exactly the same point in the vessel
- Positioning of the wires will be confirmed by X-rays
- Simultaneous measurements will be taken from the 2 pressure wires
- If there is a narrowing in more than one vessel the process will be repeated for each vessel. Once the measurement has been taken, both wires will be removed.
- Coronary artery pressure as measured by St Jude Medical Pressure Wire (SJPW) [ Time Frame: Day one ]
The study will involve the use of two pressure wires simultaneously in a coronary artery.
The three randomisation groups will allow the comparison of pressure measurements between two different wires (BSPW vs SJPW) and will document consistency of readings within the same wire (BSPW vs BSPW or SJPW vs SJPW). Measurements will be undertaken using standard drug protocols. No additional drugs will be necessary for study purposes.
- The first wire allocated at randomisation will be passed to the target measurement position in the artery
- The second wire allocated at randomisation will be passed to exactly the same point in the vessel
- Positioning of the wires will be confirmed by X-rays
- Simultaneous measurements will be taken from the 2 pressure wires
- If there is a narrowing in more than one vessel the process will be repeated for each vessel. Once the measurement has been taken, both wires will be removed.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria
- >18yrs age
- Written informed consent
- Patients scheduled for diagnostic angiography (and/or "standby" angiography)
- Clinical requirement for pressure wire assessment
Exclusion Criteria
- STEMI presentation
- Aorto-ostial disease
- Pregnancy
- CABG
- Contraindication to adenosine
- Creatinine >180umol/L
- Life threatening co-morbidity
- Severe valve disease
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02578381
| United Kingdom | |
| Liverpool Heart & Chest NHS Foundation Trust | |
| Liverpool, Merseyside, United Kingdom, L14 3PE | |
| Southampton General Hospital | |
| Southampton, United Kingdom, SO16 6YD | |
| Principal Investigator: | Nick Curzen, BM(Hons) PhD | University Hospital Southampton NHS Foundation Trust |
| Responsible Party: | University Hospital Southampton NHS Foundation Trust |
| ClinicalTrials.gov Identifier: | NCT02578381 |
| Other Study ID Numbers: |
COMET |
| First Posted: | October 19, 2015 Key Record Dates |
| Last Update Posted: | May 17, 2017 |
| Last Verified: | May 2017 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
pressure wire coronary angiogram validation |
|
Angina, Stable Angina Pectoris Myocardial Ischemia Heart Diseases Cardiovascular Diseases |
Vascular Diseases Chest Pain Pain Neurologic Manifestations |

